Additional information
White powder
4546-70-7
ACI-038101
240.6-242.9°C
C10H14N6O3
266.26
Ambient
2-8°C
Anticancer
Pharmaceutical Impurity Standards
9-(2-deoxy-ß-d-erythro-pentofuranosyl)-9H-purin-2,6-diamine
9-(2-deoxy-ß-d-erythro-pentofuranosyl)-9H-purin-2,6-diamine
(2R,3S,5R)-5-(2,6-diamino-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol





![N-ETHYL AZILSARTAN MEDOXOMIL (25 mg) ((5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{[2′-(4-ethyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylate)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)